Cai Lei Team Collaborates with Nobel Laureate Demis Hassabis’ Isomorphic Labs to Harness AI for ALS Drug Discovery

Stock trading depends onGolden Qilin Analyst Report, authoritative, professional, timely, comprehensive, help you explore potential theme opportunities!

(Source: Elephant News)

Da Xiang News Reporter Zhou Lan

On September 5, the reporter of Elephant News learned from the team of ALS fighter Cai Lei that on September 3, Cai Lei's team held an online meeting with the team from Isomorphic Labs, led by Demis Hassabis, the winner of the 2024 Nobel Prize in Chemistry, to jointly explore new AI-driven treatment approaches for ALS.

Cai Lei's team emphasized that their sole goal is to find therapies that save patients' lives, with no interest in commercial profits or academic achievements.

It is reported that蔡磊team has achieved fruitful results in the research of渐冻症in recent years. Isomorphic Labs is committed to accelerating drug research and development through artificial intelligence technology.

The reporter learned that Ouyang Binghui, the AI technology leader of Cai Lei's team, presented the team’s research achievements and cooperation foundation during the conference. He also proposed advanced directions for expected collaboration, including using AI to model the abnormal structure of TDP-43 protein aggregation and reconstructing the dynamic structure of MAM (mitochondria-endoplasmic reticulum contact sites).

This online conference focused on multiple topics, including the current state of ALS (Amyotrophic Lateral Sclerosis) research, data-driven exploration of causation, AI-assisted drug development, and potential directions for collaboration.